Unpack the World of Pills, Patents and Pharmacies For Chronics Diseases

Table of Contents

Lately, the national news has been completely flooded with Vidi Aldiano’s story and his tough journey undergoing therapy for kidney cancer. While it honestly breaks my heart. He was a decent human being and since I'm a huge fan of Sheila Dara, the wife he sweetly refers to as his "First Lady"—this news hit me on a much deeper level. In a way, it’s pretty similar to when Julia Perez passed away. It was such a wake-up call for me that I was immediately moved to go and get a Pap smear.

I couldn't help but think about the massive financial toll and just how much effort it takes to afford that kind of intensive medical treatment.

Kidney cancer is one example of a chronic disease. I’d like to dive into this wild world with a side of humor, because if we don’t laugh, we might just cry. It’s not because the pills or other medical treatments are made of solid gold (though, in this economy, especially here in Indonesia some of them sure cost like they are!).

First Things First: What Even Are Chronic Disease Medications?

Let’s start simple. Chronic diseases are the ones that stick around longer than your weird uncle at a family reunion; think conditions you manage for years, or even a lifetime. Think about diabetes or gout, they might not be immediately life-threatening, but they can haunt you forever.

The meds that treat them range from daily pills to fancy injectables, and they’re supposed to keep you healthy enough to enjoy life.

But here’s the real problem: these meds often come with price tags that make luxury items look like bargains. For example, my mother needs insulin pens, which cost at least two hundred thousand Rupiah per pen. Let’s say the monthly supply is around 800,000 Rupiah, and that's not including other necessities like alcohol swabs.

Then I realized that in the USA, the prices are even higher. Why? Because there are three key players: specialty pharmacies, the FDA, and patents.

What is Specialty Pharmacies?

Back home in Indonesia, we have the classic distinction between a Toko Obat and an Apotek. The rules are different, the former can't accept doctor's prescriptions and only stocks over-the-counter stuff.

In the US, it’s a similar vibe but with a twist: you have regular pharmacies and specialty pharmacies. Think of the regular ones as your friendly neighborhood grocery store. Meanwhile, specialty pharmacies are like those fancy gourmet markets that only sell truffle oil and artisanal cheese, except, you know, for high-stakes drugs instead of fancy snacks. One famous Specialty Pharmacies is https://www.starcarepharmacy.com, the store located in New York, U.S.

According to industry definitions, specialty pharmacies focus on high-cost, complex medications for chronic or rare conditions . We’re talking about drugs that might need to be stored at super-cold temperatures (like your ex’s heart, maybe? Hoahaha), require special training to use (hello, injectables insulin pen!), or need constant monitoring to avoid gnarly side effects .

 You can think of them as the concierge of the pharmacy world. After buying, they don’t just hand you a bottle and send you on your way home, instead, they offer things like:

Patient education

Teaching you how to inject your meds without turning your arm into a pincushion.

Financial assistance help

Hunting down coupons or programs to make your meds less painful on your wallet.

Ongoing support

Checking in to make sure the drug is working and you’re not having weird reactions 

Special handling

For example making sure meds stay chilling during shipping.

Specialty pharmacists are also a cut above the rest. They undergo extra training and can even get certified as Certified Specialty Pharmacists (CSP) . To earn that title, they need years of experience, continuing education, and a license.

The conclusion is regular retail pharmacies are great for your headaches or mild allergies but they’re not equipped to handle the drama of chronic disease meds. For example many chronic disease meds come with a long list of side effects. Specialty pharmacists can help you manage them, so you don’t have to Google “why is my skin turning blue” at 2 a.m.

But here’s the consequence : because these meds are complex and require extra care, their prices are often even higher. It’s like paying for first-class airfare, you get more perks, but your bank account will definitely notice.

The FDA: The Referee slash Rulesmaker

The U.S. Food and Drug Administration (FDA) is supposed to be the referee in this field. They making sure drugs are safe, effective, and not secretly made of candy (though that might make them more fun to take Hoahaha). But how does it tie into high drug prices? Let’s break it down.

The FDA’s Role in Approving Drugs

To get a new drug on the market, companies have to jump through more hoops than a circus dog. They run years of clinical trials, submit mountains of data, and prove their drug actually works (and isn’t more dangerous than the condition it treats).

This process is expensive, since the beginning, drug companies say they spend billions of dollars to bring a single drug to market. And guess what? They pass those costs on to you. But here’s the funny part (if you can call it that): Only about 1 in 10 drugs that start clinical trials actually make it to shelves. So companies factor in the cost of all the failed drugs when pricing the ones that work. It’s like buying a lottery ticket and making everyone else pay if you win. This is the harsh truth that we have to endure as the society globally.

As my research continue, I found out about The Hatch-Waxman Act. This act that passed in the 1980's rules to balance two things: encouraging drug companies to invent new meds, and making sure generic versions can hit the market quickly once patents expire. Here how it. Works

A brand-name drug companies get patent term extensions (PTEs) up to 5 extra years of exclusivity if the FDA takes a long time to review their drug . This is supposed to make up for the time they couldn’t sell the drug while waiting for approval.

Meanwhile, generic drug companies get a faster path to approval, so they can start selling cheaper versions once patents run out.

Sounds good in theory, right? But in practice, brand-name companies have found ways to cheat the system. The latest catch in 2025, the Federal Circuit ruled that drug companies can get full 5-year extensions even if they reissue their patents to fix errors . This means generics have to wait even longer to hit the market and we have to keep paying more money.

The FDA and Specialty Pharmacies

The FDA also plays a role in regulating specialty pharmacies, especially when it comes to compounded drugs (custom-made meds for individual patients). After a 2012 outbreak that killed over 60 people, Congress passed the Drug Quality and Security Act (DQSA) to tighten rules .

Now, “outsourcing facilities” (large-scale compounding pharmacies) have to follow stricter quality standards and get inspected by the FDA. But here’s the other news: Compounded drugs aren’t reviewed by the FDA for safety or effectiveness before they’re sold. And when compounded drugs look too much like patented brand-name meds, it can spark legal battles that keep prices high.

The Big Patent Drug Companies : the Real Gold-digger

If you’ve ever wondered why your chronic meds cost so much, look no further than drug patents. The global drug industry is ruled by a few massive companies (known as big-pharma). They have the deep pockets for huge research projects and are usually the ones pushing medical innovation forward and get the patent.

Patents give companies exclusive rights to sell a drug for 20 years from the date they file the application. During that time, they can set prices as high as the market will bear because there’s no competition.

 Then, some wicked companies don’t stop at one patent. They use a trick called patent thicketing. They filing dozens (or even hundreds) of patents on the same drug to extend their monopoly .

Is this legal? Sadly, yes. Companies argue that extra patents protect improvements to the drug (like new dosages or delivery methods). But critics say it’s just a way to keep generics off the market and prices high.

So Why Your Chronic Meds Cost a Fortune?

 Let’s recap the perfect storm that makes chronic disease meds so (d*mn) expensive:

1. High R&D costs: Drug companies spend billions to develop new meds, and they pass those costs on to you (plus extra for failed drugs). They also spent billions in advertising the drugs.
2. Patent monopolies: Companies use patents (and tricks like patent thicketing) to keep competitors at bay, letting them set sky-high prices.
3. The FDA approval process: While necessary for safety, the long review process can lead to patent extensions that delay generics.
4. Specialty pharmacy needs: Complex meds require extra care, handling, and support, all of which add to the cost.
5. No price negotiation: In the U.S. they use Free Market System, so the goverment can’t negotiate prices for most drugs, the companies can charge whatever they want.

The Patient's Reality: "Financial Toxicity"

Aside from Vidi, that I was read covered some of the med cost by insurance, If we read patient stories on social media, it's heartbreaking. Some cancer patients face bills of over $100,000 a year. People literally have to turn to crowdfunding just to pay for their treatments.

The medical world actually has a term for this: Financial Toxicity. It describes the devastating economic impact that high medical bills have on a patient's life. In some horrible cases, people have to choose between buying their life-saving meds or paying for basic living expenses.

Is There Any Hope?

Yes! While the situation feels bleak, there are glimmers of light:

Medicare negotiation

The US new program will bring down prices for some meds starting in 2026. 

Generic competition

When patents finally expire, generic versions can drop prices by 80% or more.

Patient assistance programs

Many drug companies and specialty pharmacies offer coupons or free meds to people who can’t afford them. I haven't heard it yet, here in Indonesia, but maybe we could absorbed this step.

Policy changes

 Advocates are pushing for laws to crack down on patent abuse and let the government negotiate more drug prices. Hopefully, Indonesia will strengthen it's regulations in the future too.

❤❤❤❤❤

 Last but not least, my deepest condolences to Vidi’s family and so many best friends. May he rest in eternal peace. I hope we can all take a lesson from his journey by paying closer attention to our health, especially our kidney function because, as we’ve seen, the cost of treatment is truly no joke.